Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
PF-00835231
Cathepsin L
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022
Ritonavir
Cathepsin L
Emergency use authorization Used to treat other disease Antiviral Nov/02/2021
GC376
Cathepsin L
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021
Hydroxychloroquine sulfate
Cathepsin L
Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021
Camostat mesylate
Cathepsin L
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021
N-[(2S)-1-[[(3S)-1-(benzenesulfonyl)-5-phenylpentan-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methylpiperazine-1-carboxamide
Cathepsin L
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021
Aloxistatin
Cathepsin L
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/27/2021
Amantadine
Cathepsin L
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/27/2021
Dacomitinib
Cathepsin L
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021
Indinavir
Cathepsin L
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/07/2021
Eicosapentaenoic acid
Cathepsin L
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/04/2021
Linolenic acid
Cathepsin L
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/04/2021
Calpain inhibitor II
Cathepsin L
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021
Boceprevir
Cathepsin L
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021
Calpain inhibitor XII
Cathepsin L
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021
Rupintrivir
Cathepsin L
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/17/2021
Dalbavancin
Cathepsin L
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/01/2020
Atazanavir
Cathepsin L
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/26/2020
(-)-Epicatechin
Cathepsin L
Potential treatment - theoretical effect Natural product Antiviral Oct/28/2020
Neratinib
Cathepsin L
Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/26/2020